1-20 of 73
medical devices
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study

Anna Korsgaard Berg, Annemarie Cecilie Grauslund, Fiona Sørensen, Steffen Ullitz Thorsen, Jacob P. Thyssen, Claus Zachariae, Jannet Svensson
Journal: Diabetes Care
Diabetes Care 2023;46(10):1770–1777
https://doi.org/10.2337/dc23-0462
Published: 21 July 2023
View article titled, A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study
Open the PDF for A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study in another window
Journal Articles

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

Georgia M. Davis, Anne L. Peters, Bruce W. Bode, Anders L. Carlson, Bonnie Dumais, Todd E. Vienneau, Lauren M. Huyett, Trang T. Ly
Journal: Diabetes Care
Diabetes Care 2023;46(4):742–750
https://doi.org/10.2337/dc22-1915
Published: 14 February 2023
View article titled, Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
Open the PDF for Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy in another window
Journal Articles

Index

Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S285–S291
https://doi.org/10.2337/dc23-in01
Published: 12 December 2022
View article titled, Index
Open the PDF for Index in another window
Journal Articles

7. Diabetes Technology: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S111–S127
https://doi.org/10.2337/dc23-S007
Published: 12 December 2022
View article titled, 7. Diabetes Technology: <em>Standards of Care in Diabetes</em>—<em>2023</em>
Open the PDF for 7. Diabetes Technology: <em>Standards of Care in Diabetes</em>—<em>2023</em> in another window
Journal Articles

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans
Journal: Diabetes Care
Diabetes Care 2022;45(12):3058–3074
https://doi.org/10.2337/dci22-0018
Published: 06 October 2022
View article titled, Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association
Open the PDF for Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association in another window
Journal Articles

Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes

Judith Hsia, Nicole L. Guthrie, Paul Lupinacci, Ananda Gubbi, Douglas Denham, Mark A. Berman, Marc P. Bonaca
Journal: Diabetes Care
Diabetes Care 2022;45(12):2976–2981
https://doi.org/10.2337/dc22-1099
Published: 01 October 2022
View article titled, Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes
Open the PDF for Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes in another window
Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee
Journal: Diabetes Care
Diabetes Care 2022;45(Supplement_1):S97–S112
https://doi.org/10.2337/dc22-S007
Published: 16 December 2021
View article titled, 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2022</em>
Open the PDF for 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2022</em> in another window
Journal Articles

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy, Amy B. Criego, David W. Hansen, Irl B. Hirsch, Anders L. Carlson, Richard M. Bergenstal, Jennifer L. Sherr, Sanjeev N. Mehta, Lori M. Laffel, Viral N. Shah, Anuj Bhargava, Ruth S. Weinstock, Sarah A. MacLeish, Daniel J. DeSalvo, Thomas C. Jones, Grazia Aleppo, Bruce A. Buckingham, Trang T. Ly, Omnipod 5 Research Group, Sue A. Brown, Mary Voelmle, Emma Emory, Gregory P. Forlenza, R. Paul Wadwa, Robert Slover, Erin Cobry, Laurel H. Messer, Cari Berget, Susan McCoy, Viral N. Shah, Halis K. Akturk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Perez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri L. Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy B. Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret Fisher, Rebecca Ortiz La Banca, Lisa Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily F. Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie R. Wood, Beth A. Kaminski, Terri L. Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Russel Johns, Ashwini Gore, Leslie Harvill, Kayla Merritt, Jennifer Stanfield, Jennifer Sheldon, Lisa Hichkad, Erica Burnett, Alicia Castelot, Lindsay Bounds, Kaitlyn Preston, Rebecca Goldfaden, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin
Journal: Diabetes Care
Diabetes Care 2021;44(7):1630–1640
https://doi.org/10.2337/dc21-0172
Published: 20 July 2021
View article titled, Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Open the PDF for Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes in another window
Journal Articles

Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

Nudrat Noor, Osagie Ebekozien, Laura Levin, Sheri Stone, David P. Sparling, Robert Rapaport, David M. Maahs
Journal: Diabetes Care
Diabetes Care 2021;44(8):e160–e162
https://doi.org/10.2337/dc21-0074
Published: 18 June 2021
View article titled, Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
Open the PDF for Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry in another window
Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2021

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2021;44(Supplement_1):S85–S99
https://doi.org/10.2337/dc21-S007
Published: 04 December 2020
View article titled, 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2021</em>
Open the PDF for 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2021</em> in another window
Journal Articles

Sedentary Time and Metabolic Risk in Extremely Active Older Adults

Kenneth M. Madden, Boris Feldman, Jocelyn Chase
Journal: Diabetes Care
Diabetes Care 2021;44(1):194–200
https://doi.org/10.2337/dc20-0849
Published: 16 October 2020
View article titled, Sedentary Time and Metabolic Risk in Extremely Active Older Adults
Open the PDF for Sedentary Time and Metabolic Risk in Extremely Active Older Adults in another window
Journal Articles

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Sara Vogrin, Martin I. de Bock, Mary B. Abraham, Leon A. Bach, Morton G. Burt, Neale D. Cohen, Peter G. Colman, Elizabeth A. Davis, Christel Hendrieckx, D. Jane Holmes-Walker, Joey Kaye, Anthony C. Keech, Kavita Kumareswaran, Richard J. MacIsaac, Roland W. McCallum, Catriona M. Sims, Jane Speight, Stephen N. Stranks, Vijaya Sundararajan, Steven Trawley, Glenn M. Ward, Alicia J. Jenkins, Timothy W. Jones, David N. O’Neal, Australian JDRF Closed-Loop Research Group, David N. O’Neal, Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Catriona M. Sims, Richard J. MacIsaac, Glenn M. Ward, Peter G. Colman, Neale D. Cohen, Leon A. Bach, Kavita Kumareswaran, Stephen N. Stranks, Morton G. Burt, D. Jane Holmes-Walker, Roland W. McCallum, Joey Kaye, Jane Speight, Christel Hendrieckx, Jennifer Halliday, Sienna Russell-Green, Steven Trawley, Alicia J. Jenkins, Andrzej Januszewski, Anthony C. Keech, Sara Vogrin, Vijaya Sundararajan, Hanafi Mohammed Husin, Philip M. Clarke, Timothy W. Jones, Elizabeth A. Davis, Martin I. de Bock, Mary B. Abraham, Geoff R. Ambler, Fergus J. Cameron, Jan M. Fairchild, Bruce R. King
Journal: Diabetes Care
Diabetes Care 2020;43(12):3024–3033
https://doi.org/10.2337/dc20-1447
Published: 14 October 2020
View article titled, Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
Open the PDF for Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial in another window
Journal Articles

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Sue A. Brown, Roy W. Beck, Dan Raghinaru, Bruce A. Buckingham, Lori M. Laffel, R. Paul Wadwa, Yogish C. Kudva, Carol J. Levy, Jordan E. Pinsker, Eyal Dassau, Francis J. Doyle, III, Louise Ambler-Osborn, Stacey M. Anderson, Mei Mei Church, Laya Ekhlaspour, Gregory P. Forlenza, Camilla Levister, Vinaya Simha, Marc D. Breton, Craig Kollman, John W. Lum, Boris P. Kovatchev, iDCL Trial Research Group, Boris Kovatchev, Stacey Anderson, Emma Emory, Mary Voelmle, Katie Conshafter, Kim Morris, Mary Oliveri, Linda Gondor-Fredrick, Harry Mitchell, Kayla Calvo, Christian Wakeman, Marc Breton, Lori Laffel, Elvira Isganaitis, Louise Ambler-Osborn, Emily Flint, Kenny Kim, Lindsay Roethke, Jordan Pinsker, Mei Mei Church, Camille Andre, Molly Piper, Carol Levy, David Lam, Grenye O’Malley, Camilla Levister, Selassie Ogyaadu, Jessica Lovett, Yogish C. Kudva, Vinaya Simha, Vikash Dadlani, Shelly McCrady-Spitzer, Corey Reid, Kanchan Kumari, R. Paul Wadwa, Greg Forlenza, G. Todd Alonso, Robert Slover, Emily Jost, Laurel Messer, Cari Berget, Lindsey Towers, Alex Rossick-Solis, Bruce Buckingham, Laya Ekhlaspour, Tali Jacobson, Marissa Town, Ideen Tabatabai, Jordan Keller, Evalina Salas, Francis Doyle, III, Eyal Dassau, John Lum, Roy Beck, Samantha Passman, Tiffany Campos, Dan Raghinaru, Craig Kollman, Carlos Murphy, Nandan Patibandla, Sarah Borgman, Guillermo Arreza-Rubin, Thomas Eggerman, Neal Green, Boris Kovatchev, Sue Brown, Stacey Anderson, Marc Breton, Lori Laffel, Jordan Pinsker, Carol Levy, Yogish C. Kudva, R. Paul Wadwa, Bruce Buckingham, Francis Doyle III, Eric Renard, Claudio Cobelli, Yves Reznik, Guillermo Arreza-Rubin, John Lum, Roy Beck, Robert Janicek, Deanna Gabrielson, Steven H. Belle, Jessica Castle, Jennifer Green, Laurent Legault, Steven M. Willi, Carol Wysham, Thomas Eggerman
Journal: Diabetes Care
Diabetes Care 2020;43(8):1822–1828
https://doi.org/10.2337/dc20-0124
Published: 29 May 2020
View article titled, Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Open the PDF for Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial in another window
Journal Articles

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Sara Charleer, Christophe De Block, Liesbeth Van Huffel, Ben Broos, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard
Journal: Diabetes Care
Diabetes Care 2020;43(2):389–397
https://doi.org/10.2337/dc19-1610
Published: 16 December 2019
View article titled, Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
Open the PDF for Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study in another window
Includes: Supplementary data
Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2020

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2020;43(Supplement_1):S77–S88
https://doi.org/10.2337/dc20-S007
Published: 16 December 2019
View article titled, 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2020</em>
Open the PDF for 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2020</em> in another window
Journal Articles

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

G. Alexander Fleming, John R. Petrie, Richard M. Bergenstal, Reinhard W. Holl, Anne L. Peters, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2020;43(1):250–260
https://doi.org/10.2337/dci19-0062
Published: 12 December 2019
View article titled, Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Open the PDF for Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group in another window
Journal Articles

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Rayhan A. Lal, Marina Basina, David M. Maahs, Korey Hood, Bruce Buckingham, Darrell M. Wilson
Journal: Diabetes Care
Diabetes Care 2019;42(12):2190–2196
https://doi.org/10.2337/dc19-0855
Published: 23 September 2019
View article titled, One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System
Open the PDF for One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System in another window
Includes: Supplementary data
Journal Articles

Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting

Frank D. Verbraak, Michael D. Abramoff, Gonny C.F. Bausch, Caroline Klaver, Giel Nijpels, Reinier O. Schlingemann, Amber A. van der Heijden
Journal: Diabetes Care
Diabetes Care 2019;42(4):651–656
https://doi.org/10.2337/dc18-0148
Published: 14 February 2019
View article titled, Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting
Open the PDF for Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting in another window
Includes: Supplementary data
Journal Articles

7. Diabetes Technology: Standards of Medical Care in Diabetes—2019

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2019;42(Supplement_1):S71–S80
https://doi.org/10.2337/dc19-S007
Published: 07 December 2018
View article titled, 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2019</em>
Open the PDF for 7. Diabetes Technology: <em>Standards of Medical Care in Diabetes—2019</em> in another window
Journal Articles

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study

Robert R. Henry, Julio Rosenstock, Douglas S. Denham, Prakash Prabhakar, Lise Kjems, Michelle A. Baron
Journal: Diabetes Care
Diabetes Care 2018;41(3):613–619
https://doi.org/10.2337/dc17-1519
Published: 04 January 2018
View article titled, Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA<sub>1c</sub>: The FREEDOM-1 HBL (High Baseline) Study
Open the PDF for Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA<sub>1c</sub>: The FREEDOM-1 HBL (High Baseline) Study in another window
Includes: Supplementary data